BILL
Bill.com Holdings, Inc.
BILL trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over BILL overall, supported by stronger valuation and stronger modeled upside.
BILL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Weak |
BILL's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is weak.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BILL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $54.00 | — |
| Cheap | 99x | $52.67 | -2.5% |
| Fair | 100x | $53.20 | -1.5% |
| Expensive | 101x | $53.73 | -0.5% |
| Current | 102x | $54.00 | — |
Historical ranges are pointers, not guarantees.
BILL's PE is 102x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over BILL in the historical PE scenario, which offers more potential upside but is not a forecast.
BILL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect BILL's earnings to grow and its profitability to improve, but its revenue to decline.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
BILL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.08 | +670% |
| Q4 2023 | -$1.07 | +$2.26 |
| Q3 2023 | -$1.59 | +$1.62 |
| Q2 2023 | -$2.11 | +$1.11 |
| Q1 2023 | -$2.78 | +$0.13 |
| Q4 2022 | -$3.33 | -$0.94 |
| Q3 2022 | -$3.21 | -$1.39 |
| Q2 2022 | -$3.22 | -$2.03 |
| Q1 2022 | -$2.91 | -$2.09 |
NVDA has the stronger earnings trend. Trailing diluted EPS is down 67% for BILL versus NVDA up 125%.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
BILL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $353.8M | -11% |
| Q2 2026 | $436.2M | +14% |
| Q1 2026 | $406.6M | +13% |
| Q4 2025 | $414.7M | +14% |
| Q3 2025 | $395.7M | +10% |
| Q2 2025 | $383.3M | +12% |
| Q1 2025 | $358.2M | +11% |
| Q4 2024 | $362.6M | +14% |
BILL's revenue is growing: $354M last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +20 points |
| Q2 2026 | -7.8% | -2 points |
| Q1 2026 | -0.1% | +8 points |
| Q4 2025 | -4.4% | +1.6 points |
| Q3 2025 | -5.2% | -3.1 points |
| Q2 2025 | -5.8% | +0.7 points |
| Q1 2025 | -8.1% | +0.5 points |
| Q4 2024 | -6% | +15 points |
BILL's operating margin was 14% last quarter, up 20 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over BILL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over BILL on profitability, with a higher operating margin.
BILL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $96.7M | +1.2% |
| Q2 2026 | $110.6M | +37% |
| Q4 2025 | $103.8M | +32% |
| Q3 2025 | $95.6M | +7.9% |
| Q2 2025 | $81M | +3.3% |
| Q4 2024 | $78.7M | -0.8% |
| Q3 2024 | $88.6M | +66% |
| Q2 2024 | $78.4M | -1.1% |
BILL generated $414M in free cash flow over the past year, up 20% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over BILL on cash flow, with more consistent year-over-year improvement.
BILL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +1M shares |
| 1 year | -0.9% | -955K shares |
| 3 years | -4.7% | -5M shares |
| 5 years | +22% | +18.2M shares |
| Available history | +353% | +78.7M shares |
BILL has 101M diluted shares, down 0.9% from a year ago, with $790M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $312.2M |
| Q2 2026 | $287.8M |
| Q1 2026 | $56.9M |
| Q4 2025 | $132.7M |
| Q3 2025 | $83.1M |
| Q2 2025 | $30M |
| Q1 2025 | — |
| Q4 2024 | $200M |
BILL spent $790M buying back its own shares over the past year, up 152% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over BILL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BILL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 29.0x | High |
BILL's net debt is more than 20 years of its operating earnings (EBITDA).
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over BILL on leverage, with a lower net debt burden relative to earnings.
BILL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 81.8 | Overbought |
BILL's weekly RSI is 63 (neutral) and its Stochastic is 82 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BILL PE vs Technology Sector
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
BILL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.0 | 13% above |
| 20 week MA | $46.9 | 15% above |
| 50 week MA | $44.6 | 21% above |
| 100 week MA | $49.0 | 10% above |
| 200 week MA | $63.8 | 15% below |
BILL has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BILL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2019 | $39.0 | $38.6 | -1% |
| 2020 | $38.6 | $148.4 | +285% |
| 2021 | $148.4 | $253.4 | +71% |
| 2022 | $253.4 | $103.7 | -59% |
| 2023 | $103.7 | $81.6 | -21% |
| 2024 | $81.6 | $86.9 | +6.6% |
| 2025 | $86.9 | $55.2 | -36% |
| 2026 YTD | $55.2 | $54.0 | -2.2% |
BILL has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.